The company has informed that the transfer of 16,04,603 shares of Navana Pharmaceuticals PLC held by Mr. Manzurul Islam (Sponsor), transferor, to Dr. Md. Jonaid Shafiq (Managing Director), transferee, has been completed outside the trading system of the Exchange other than by way of gift as per declaration disseminated on 04.08.2026.

(cont. news of NAVANAPHAR): Mrs. Saiqa Mazed-Chairman and Independent Director, Professor Dr. Md. Jonaid Shafiq-Managing Director, Dr. Sayeed Ahmed-Director, Mr. Javed Kaiser Ally-Director, Mrs. Tarana Ahmed-Director, Mrs. Masuma Parvin-Director, Mr. Khondaker Sabbir Mohammad Kabir (Nominee of Stratus Holdings Limited)-Director, Mr. Mohammad Arife Billah (Bar-At-Law)-Independent Director, Professor Mohammad Shofiqul Islam-Independent Director. (end)

Dhaka Stock Exchange PLC. (DSE) has approved the transfer of 16,04,603 shares of Navana Pharmaceuticals PLC held by Mr. Manzurul Islam (Sponsor), transferor, to Dr. Md. Jonaid Shafiq (Managing Director), transferee, within next 30 working days with effect from August 02, 2026 outside the trading system of the Exchange other than by way of gift under Regulation 47(1)(b) of the Dhaka Stock Exchange (Listing) Regulations, 2015 as well as other applicable laws.

(Cont. news of NAVANAPHAR): 2. The Company has decided to proceed with a Foreign Loan Facilities for EUR 26,610,000.00 for 12 years from AKA Ausfuhrkredit-Gesellschaft mbH, Frankfurt, Germany, the sole arranger of which is KGMC Financial Service, Bangladesh. The Company has decided to avail the aforesaid facilities for expansion of its production facilities. The proposed financing shall remain subject to final approval from the concerned regulatory authorities & completion of due diligence. (end)

The Company has informed that Mr. Lorens Shamol Mollick, FCS continues to legally hold his position as the official Company Secretary of Navana Pharmaceuticals PLC.

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on June 03, 2026 at 3:00 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended March 31, 2026.

The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2025 to the respective shareholders.

The company has informed that the Board of Directors has elected Mr. Javed Kaiser Ally as the Chairman of the Board of the Company with immediate effect.

The Company has informed that the Board of Directors has decided to appoint Dr. Sayeed Ahmed as the Managing Director of the company with immediate effect.

The Company has informed that the Board of Directors has decided to appoint Mr. Md. Aminul Hoque Bhuiyan, ACS as the Acting Company Secretary of the company with immediate effect.